EE327 Belantamab Mafodotin, Pomalidomide, and Dexamethasone (BPd) in Relapsed/Refractory Multiple Myeloma (RRMM): Quality-Adjusted Life-Year (QALY) Results From a Cost-Effectiveness Model. - Suvannasankha, Attaya; Kaiser, Martin; Lee, Dawn; Dlotko, Ewa; Macleod, Paul; Boytsov, Natalie; Crossman-Morgan, Christina-Jane; Jadhav, Vinay; Kazeem, Gbenga; Merchant, Adil; Purser, Molly; Riemer, Justin; et al. (Value in Health, 2025)